Amylyx Pharmaceuticals, Inc. (AMLX) /
The revenue of Amylyx Pharmaceuticals, Inc. over the past 5 years
Chart Amylyx Pharmaceuticals, Inc.: revenue, fiscal 2021–2025 Open the chart →Amylyx Pharmaceuticals, Inc. reported revenue of $0 in fiscal 2025, the latest fiscal year on file. In fiscal 2021 it was $285K. Year over year, revenue rose twice and fell twice. In these years the highest was $380.79M in fiscal 2023; the lowest $0 in fiscal 2025. The largest one-year move was in fiscal 2022: up 7700%, from $285K to $22.23M.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | $0 |
| 2024ended Dec 31, 2024 | $87.37M |
| 2023ended Dec 31, 2023 | $380.79M |
| 2022ended Dec 31, 2022 | $22.23M |
| 2021ended Dec 31, 2021 | $285K |
Fiscal years as Amylyx Pharmaceuticals, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Amylyx Pharmaceuticals, Inc.
- The profitability of Amylyx Pharmaceuticals, Inc.
- The cash flow of Amylyx Pharmaceuticals, Inc.
- The debt of Amylyx Pharmaceuticals, Inc.
- All of Amylyx Pharmaceuticals, Inc.'s financials, charted
Companies of a similar size
- CLBTCellebrite DI Ltd.
- IMAXIMAX Corporation
- KNFKnife River Corporation
- AVAHAveanna Healthcare Holdings Inc.
- EEFTEURONET WORLDWIDE, INC.
Not investment advice. This page shows what Amylyx Pharmaceuticals, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.